These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11477888

  • 1. [Efficacy of regimens containing INH, RFP with varied chemotherapy courses on retreated culture positive pneumoconio-tuberculosis].
    Jiang W, Chen H, Gao J, Huaibei M.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):648-50. PubMed ID: 11477888
    [Abstract] [Full Text] [Related]

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 3. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK.
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of unfixed continuation phase short-course chemotherapy].
    Xiao C, Fu Y, Li Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):358-60. PubMed ID: 10374447
    [Abstract] [Full Text] [Related]

  • 5. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
    Yan S, Ye H, Lin S.
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851
    [Abstract] [Full Text] [Related]

  • 6. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
    Chu N, Yan B, Zhu L.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):164-6. PubMed ID: 10072822
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
    Wada M, Seita A, Mori T, Ogata H, Sugie T, Sugita H.
    Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
    [Abstract] [Full Text] [Related]

  • 13. [Long-term results of short-course chemotherapy in pulmonary tuberculosis (final report). The third study: comparative study of two regimens, 6RHZ and -6RHS (treatment was continued for 6 months after negative conversion of sputum by culture)].
    Baba H, Shinkai A, Izuchi R, Azuma Y.
    Kekkaku; 1988 Apr; 63(4):239-46. PubMed ID: 3136270
    [No Abstract] [Full Text] [Related]

  • 14. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ, Perng RP.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Randomised controlled clinical trial of short course chemotherapy in abdominal tuberculosis: a five-year report.
    Balasubramanian R, Nagarajan M, Balambal R, Tripathy SP, Sundararaman R, Venkatesan P, Paramasivam CN, Rajasambandam P, Rangabashyam N, Prabhakar R.
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):44-51. PubMed ID: 9441058
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A short course of chemotherapy in newly diagnosed and retreatment of smear-positive pulmonary tuberculosis in a rural area].
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug; 12(4):220-2, 254-5. PubMed ID: 2636947
    [Abstract] [Full Text] [Related]

  • 19. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T, Rehman F, Mitchison DA, Sarma GR, Reetha AM, Prabhaker R, Tuberculosis Research Centre, Indian Council of Medical Research.
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [Abstract] [Full Text] [Related]

  • 20. [Controlled clinical study on efficacy of fixed-dose compounds rifater/rifinah in antituberculous chemotherapy].
    Zhu L, Yan B, Ma W.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):645-7. PubMed ID: 11477887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.